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Abstract. Studies in recent years have led to a better understanding of the mechanisms 
by which obesity is closely linked to metabolic syndrome and its complications. Biomarkers 
of inflammation such as tumor necrosis factor α (TNF-α), leukocyte counts, interleukin 6 (IL-
6), and C-reactive protein, have increased values in obesity and are used in prognosis of 
insulin resistance, type 2 diabetes and cardiovascular diseases. It is known that obesity is 
associated with a chronic inflammatory response, characterized by abnormal production of 
cytokines and activation of inflammatory signaling pathways. Recent studies in rats have 
shown that in obesity the adipose tissue is infiltrated by macrophages and thus activation of 
several inflammatory response genes. iNOS expression may be one's response to this 
activation. iNOS expression is regulated at a transcriptional level, and once activated, the 
enzyme can generate large amounts over a long period of time. Thus, in the early stages of 
obesity has been an increase in the amount of NO, not a decrease. The purpose of this paper is 
on determining the quantitative iNOS expression in macrophages and endothelial cells from 
adipose tissue harvested from two areas: subcutaneous fat and the greater omentum. It will 
also be evaluated the correlation between the amount of iNOS and the number of iNOS 
positive cells and the correlation between the degree of obesity and the quantitative 
expression of iNOS. 
 




Obesity is responsible for growth in excess of oxidative stress that contributes to a 
large number of cardiovascular diseases (Keaney JF col, 2003). Obesity itself is considered a 
chronic oxidative stress and inflammation even in the absence of other factors that could 
cause cardiovascular diseases (Higdon JV et al., 2003). Animal studies have shown that 
obesity leads to increased oxidative stress in the myocardium (Vincent A. et al., 1999) and 
increased lipid peroxidation (Dobrian D. et al., 2000). Blood plasma, responsible for 
transporting LDL, has a wide range of antioxidant defense mechanisms (Stocker et al., 1991), 
including a number of antioxidant proteins, mainly metal chelation proteins and enzymes. 
Oxidative stress can be followed by biological makers (antioxidants and oxidants) that are 
found in plasma and erythrocytes (Pass et al., 2001).Overweight and obese animals have a 
high rate of mortality due to cardiovascular diseases such as atherosclerosis (Eckel et al., 
2002). There are at least three ways in which obesity plays an individual can produce lipid 
peroxidation. Obesity increases metabolic activity and myocardial contraction, thereby 
increasing oxygen consumption at this level (Olusi et al., 2002). A negative effect of oxygen 
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consumption at this level is the production of reactive oxygen species such as superoxide, 
hydrogen radicals and hydrogen peroxide resulting from mitochondrial respiration (Turrens, 
1997). The second mechanism by which obesity induces increased stress oxidaiv is the 
repeated insults to cells caused by the pressure exerted on them. Lesions in cellular tissue 
causes the release of cytokines, particularly tumor necrosis factor alpha responsible for, which 
generates reactive oxygen species (Lechieitner col, 2000). A third possible mechanism is 
through diet, hyperlipidemia, lipids are involved in oxygen metabolism. If these reactive 
oxygen species production is beyond the capacity of the cell antioxidant, oxidative stress 
resulting from lipid peroxidation process can lead to atherosclerosis. 
 
MATERIALS AND METHODS 
 
The biological material consisted of 10 biopsies (samples of 5-6 cm3) of adipose 
tissue taken intraoperatively from two regions, namely subcutaneous and adipose tissue from 
the omentum. Adipose tissue samples were collected during various surgical procedures, most 
being done for gastroplasty. 
The samples were fixed in 10% neutral buffered formaline and embedded in paraffin. 
Immunohistochemistry was done using a rabbit polyclonal antibody to human iNOS 
(ab15323, Abcam, UK). For immunohistochemistry sections of 4 mm were mounted on poly-
L lysine coated slides and stored for a maximum of 48 hours at room temperature until use. 
The slides were deparaffinized using xylene. Antigen retrieval solution was realized using a 
pressurized cooker in citrate solution, pH=6. Endogenous peroxidase was inactivated using 
peroxidase blocking reagent (Dako) during 5 minutes at room temperature. Primary 
polyclonal antoibodies were maintained overnight at 4°C, using a dilution of 1:100 (Dako 
antibody diluent). The visualization of the immunological reaction was done using Universal 
LSAB+Kit/HRP, Rb/Mo/Goat (DAB+) system (Dako); counterstaining was performed using 
Mayer’s hematoxylin. 
The slides were examined under an Olympus BX 51 microscope, and the images were 
taken using an Olympus DP 25 digital camera and processed using the Olypmus Cell B image 
acquisition and processing software. 
The quantitative expression of iNOS in macrophages and endothelial cells was 
determined using image program software DP 5, by measurement of color intensity for red, 
green and blue. The blue color intensity was not measured, because it was mainly due to 
hematoxylin counterstaining. Setting the coefficient of intensity was made by calculating the 
difference in intensity between red and green. To obtain the final results of intensity ratio was 
multiplied by the number of macrophages and endothelial cells that were iNOS positive. 
 
RESULTS AND DISCUSSIONS 
 
Macrophages iNOS expression increases with BMI only in patients with degrees of 
obesity from overweight to grade II. In the grade III obesity, morbid obesity,it decreases with 
the BMI value. Also in grade III obesity patients iNOS expression of macrophages is higher 
in the omentum, when patients with overweight or grade I, II obesity iNOS expression of 
macrophages is higher the subcutaneous fat. The differences are not statistically assured. The 
iNOS expression of macrophages is explained by much higher number of macrophages in 
adipose tissue than in other regions, so it is concluded that the intensity of iNOS expression in 
macrophages infiltrate is preserve the tissues. iNOS expression of macrophages can be seen in 
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fig. 1. There is no correlation between iNOS expression intensity and BMI, which is ensured 
statistically. 
 
Fig.1. Quantification of iNOS positive macrophages according to BMI. 
 
There was no correlation between iNOS expression of endothelial cells and BMI. 
However you can see a sharp decrease in the expression of iNOS in proportion to the increase 
of BMI, but only in patients with grade III obesity, and only in the omentum adipose tissue. 
Also there was no correlation between iNOS expression by endothelial cells of the two areas 
studied. The results are shown in fig.2. 
  Quantification of iNOS expression by all iNOS positive cells revealed a higher value 
at the omentum than the subcutaneous fat, except one case, on which the amount of 
subcutaneous adipose tissue iNOS expression was higher than that of the omentum. In 
contrast, there was no correlation between the iNOS positive cells expression andn BMI. The 
values obtained can be seen in fig. 3. 
 
 
Fig. 2. Quantification of iNOS positive endothelial cells according to BMI. 
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To establish the total quantity of iNOS for each individual, we used a coefficient that 
was the quotient of each individual BMI over the BMI mean for normal-weight people, which 
is 21.7.  
Total iNOS expression revealed a significant increase in both areas studied, increase 
which was proportional to the BMI value. This fact demonstrates that the intensity of iNOS 
expression is directly proportional with BMI, and hence the degree of obesity. Total iNOS 
expression is higher in the omentum adipose tissue,  compared with subcutaneous fat. The 
results can be seen in fig. 4. 
 
 
Fig. 3. Quantification of total iNOS positive cells according to BMI. 
 
 







 iNOS expression of macrophages in adipose tissue is increased in the subcutaneous fat 
rather than in the omentum, but only in patients with degrees of obesity from overweight 
to grade II. In grade III obese patients iNOS expression of macrophages is higher in the 
omentum. 
 There could not be established a correlation between endothelial cells iNOS expression 
and BMI. It also has not been established any correlation between iNOS expression in the 
endothelial cells of the two areas studied. 
 iNOS expression of positive macrophages and endothelial cells revealed a significant 
increase at the omentum, rather than of subcutaneous fat tissue.  
 total iNOS expression revealed a significant increase in adipose tissue from both regions 
(omentum, subcutaneously) proportional to BMI value, which means that in overweight 
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